close
  • Home
  • #WE-WONT-REST
    chevron_right
  • News & Events
    chevron_right
  • About medicines
    chevron_right
  • More Than Medicine
    chevron_right
  • Pharmaceutical Legislation
  • Relationships & code
    chevron_right
  • Publications
    chevron_right
  • About us
    chevron_right
  • Contact us
  • KMS Login
arrow_back close
  • #WE-WONT-REST
  • Patient stories expand_more expand_less chevron_right
    • Alzheimer's patient story
    • Blood cancer patient story
    • Lung cancer patient story
    • Haemophilia patient story
  • Members updates
  • Imagine
  • News & Events
  • The EFPIA View
  • Events
  • Newsletter
  • About medicines
  • Development of medicines expand_more expand_less chevron_right
    • Animal Use and Welfare
    • Antimicrobial resistance (AMR)
    • Digital Health
    • Intellectual Property
    • Precision medicine
    • Public-private partnerships
    • Regulations, safety & supply
    • SMEs in Europe
    • Trade
    • Unmet medical need
  • Use of medicines expand_more expand_less chevron_right
    • HTA & Relative Efficacy Assessment
    • Disease-specific groups
    • Healthcare Systems
    • Value of medicines
  • Access to medicines expand_more expand_less chevron_right
    • Back Innovation, Boost Access
  • More Than Medicine
  • Improving Health
  • Turning science into new medicines
  • Responsible Innovation
  • Economic impact
  • Pharmaceutical Legislation
  • Relationships & code
  • The EFPIA Code
  • Patient organisations
  • Healthcare professionals (HCPs)
  • Disclosure of payments
  • National codes
  • EU institutions
  • Publications
  • Data center
  • Downloads
  • Cancer Comparator Report expand_more expand_less chevron_right
    • About
    • Recommendations
    • Cancer Cases
    • Cancer Deaths
    • Survival
    • Cancer Care
    • Cancer Types
    • Resources
  • About us
  • Who we are
  • EFPIA Japan
  • Membership
  • Job vacancies
  • Partnerships & Initiatives
  • Contact us
arrow_back close
  • Development of medicines
  • Animal Use and Welfare
  • Antimicrobial resistance (AMR)
  • Digital Health
  • Intellectual Property
  • Precision medicine
  • Public-private partnerships
  • Regulations, safety & supply
  • SMEs in Europe
  • Trade
  • Unmet medical need
  • Use of medicines
  • HTA & Relative Efficacy Assessment
  • Disease-specific groups
  • Healthcare Systems
  • Value of medicines
  • Access to medicines
  • Back Innovation, Boost Access
  • Cancer Comparator Report
  • About
  • Recommendations
  • Cancer Cases
  • Cancer Deaths
  • Survival
  • Cancer Care
  • Cancer Types
  • Resources
News & Events
Events
13th Annual Meeting... 13th Annual Meeting of ISMPP
close

13th Annual Meeting of ISMPP

Global Publication Practices: Advancing Ethics and Scientific Integrity in an Era of Data-Sharing

apps Events
chevron_left Previous
print Print
Next chevron_right

Global Publication Practices: Advancing Ethics and Scientific Integrity in an Era of Data-Sharing National Harbor, Maryland, USA

01.05.17 - 03.03.17
Event Website

This year’s theme and session topics highlight the ever-expanding area of data sharing. The debate about data sharing has shifted from “should we?” to “how do we?” This is a time when ethics and scientific integrity are even more critical as data sharing connects researchers more closely and global requirements begin to emerge.

The aim of the 13th Annual Meeting of ISMPP is to:

• Understand recent developments in key areas such as data sharing, peer-review, and payer requirements
• Enable medical publication professionals to positively impact publication practices across global markets
• Extend learning opportunities on innovative ways to work smarter and faster at the speed of business

  • Vaccines Europe
  • IMI Europe
  • 4 Ethics
  • EMVO
  • ICH
  • IHI
EFPIA 2025 All rights reserved
Privacy Policy - Change your consent
  • Vaccines Europe
  • IMI Europe
  • 4 Ethics
  • EMVO
  • ICH
  • IHI
EFPIA 2016-2023 All rights reserved
Disclaimer - Change your consent

close
continue